[20261201] University of Oxford: PhD Studentship in The Double Life of E. Coli as Benign Commensal and Deadly Pathogen, the COHORT-Microbiome Study

The University of Oxford’s Nuffield Department of Medicine invites applications for a full-time PhD studentship investigating the dual role of Escherichia coli (E. coli) as a harmless member of the human gut microbiome and a major cause of serious infections. The COHORT-Microbiome project combines long-read genomic sequencing, bioinformatics, clinical data analysis, and laboratory research to investigate bacterial colonization dynamics and infection risk. Applications are open to UK, EU, and international students, with international funding subject to securing an NDM studentship.

Important Dates / Deadline

  • Application Deadline: December 1, 2026
  • Study Level: PhD
  • Study Mode: Full-time

Organization

  • Institution: University of Oxford
  • Department: Nuffield Department of Medicine (NDM)
  • Research Project: The Double Life of E. Coli as Benign Commensal and Deadly Pathogen: the COHORT-Microbiome Study
  • Collaborating Organizations: Oxford Vaccine Group and Ellison Institute of Technology
  • COHORT Study Principal Investigator: Professor Susanna Dunachie

The project is part of the wider COHORT study, which investigates immunological responses to E. coli among participants across a spectrum of health and disease.

The COHORT-Microbiome component expands this research by incorporating longitudinal fecal sampling and microbiome profiling to understand bacterial colonization and its relationship with future infection risk.

Location / Study Destination

United Kingdom, Oxford, at John Radcliffe Hospital, within the University of Oxford’s Nuffield Department of Medicine.

Who Can Apply

The studentship is open to the following applicant categories:

  • UK students
  • EU students
  • International students
  • Self-funded students

The project is particularly suited to prospective doctoral researchers interested in:

  • Microbiology and infectious diseases
  • Human gut microbiome research
  • Microbial genomics
  • Bioinformatics and metagenomics
  • Molecular epidemiology
  • Clinical research and biomedical data analysis
  • Experimental laboratory research

The research environment is designed for students interested in developing both computational and experimental laboratory skills while working within an interdisciplinary team.

Key Benefits / Salary / Funding

Funding eligibility covers both Home Fee Status and international applicants, subject to the relevant studentship arrangements.

  • Minimum Funding Category: Home-fee student.
  • Maximum Funding Category: International student, subject to securing an NDM studentship.
  • Study Mode: Full-time.
  • Self-Funded Applications: Accepted.

Research and Training Opportunities

The successful candidate will benefit from:

  1. Access to long-read genomic sequencing facilities within the research unit.
  2. Training in advanced metagenomic sequencing and bioinformatic analysis.
  3. Opportunities to analyze detailed clinical information from electronic healthcare records.
  4. Practical experience in laboratory-based microbiological investigations.
  5. Interdisciplinary collaboration involving microbiology, genomics, immunology, and clinical research.
  6. Potential collaborative analysis of combined microbiome and immunological datasets.
  7. Participation in a research project addressing clinically significant bacterial infections.

Main Requirements

The project seeks a motivated doctoral researcher interested in combining computational and experimental approaches to investigate infectious disease.

Research Focus and Responsibilities

The successful candidate will undertake research activities including:

1. Microbial Genomics: Generate high-quality genomic datasets using long-read sequencing technologies.

2. Clinical Data Integration: Link genomic information with detailed clinical metadata obtained from electronic healthcare records.

3. Bioinformatics and Metagenomics: Apply recently developed computational methods for strain deconvolution in long-read metagenomic samples.

4. Longitudinal Microbiome Analysis: Investigate the colonization and persistence of E. coli strains in patients at risk of invasive infection and compare findings with healthy controls.

5. Infection Risk Assessment: Explore relationships between E. coli ecology, the wider gut microbiome, and subsequent infection risk.

6. Experimental Laboratory Research: Conduct in vitro studies to investigate interactions between bacterial colonization dynamics, microbiome composition, and antibiotic exposure.

7. Collaborative Research: Potentially contribute to exploratory analyses integrating microbiome and immunological datasets.

Research Background

E. coli is commonly found in the human gut without causing disease. However, certain strains are associated with urinary tract infections and bloodstream infections that can result in substantial illness and mortality.

Previous research has demonstrated that although thousands of E. coli sequence types are known, only four account for approximately 50% of bloodstream infections in England.

The project aims to determine whether these strains cause invasive infections because they are inherently more pathogenic or because they are particularly effective at colonizing and persisting in the human gastrointestinal tract.

Important Notes

  • The studentship is based at John Radcliffe Hospital in Oxford.
  • Applications are open to UK, EU, and international students, as well as self-funded candidates.
  • International funding is conditional on securing an NDM studentship.
  • The research combines computational bioinformatics with experimental microbiology.
  • The project includes longitudinal fecal sampling and analysis of microbiome changes over time.
  • Clinical metadata from electronic healthcare records will be integrated with genomic sequencing data.
  • The student may have opportunities to collaborate on combined microbiome and immunological analyses.
  • The findings are expected to improve understanding of E. coli colonization, pathogenicity, and infection risk, potentially informing interventions to reduce the burden of invasive bacterial disease.

Leave a Comment